Dual X-ray absorptiometry: Cross-calibration of a new fan-beam system

Calcified Tissue International

Volumn 75, Issue 1, 2004, Pages 7-14

  Blake, G M ^a   Harrison, E J ^b   Adams, J E ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cross calibration; Dual X ray absorptiometry; Longitudinal studies

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CALIBRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EQUIPMENT; FEMALE; HIP; HUMAN; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 3342969287     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0169-y     Document Type: Article

References (38)

1. Genant HK, Engelke K, Fuerst T (1996) Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11:707-730
2. Baran DT, Faulkner KG, Genant HK (1997) Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry. Calcif Tissue Int 61:433-440
3. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and treatment of osteoporosis. Osteoporos Int 7:390-406
4. Kanis JA, Glüer C-C (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192-202
5. Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285-289
6. Schurch M-A, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour J-P (1996) A prospective study on socio-economic aspects of fracture of the proximal femur. Bone Miner Res 11:1935-1942
7. Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35
8. Black DM, Cummings SR, Karpf DB (1996) Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541
9. Ettinger B, Black DM, Mitlak BH (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282:637-645
10. Harris ST, Watts NB, Genant HK (1999) Effects of risedrpnate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282:1344-1352
11. Neer RM, Arnaud CD, Zanchetta JR (2001) Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med 344:1434-1441
12. Royal College of Physicians (1999) Osteoporosis: clinical guidelines for prevention and treatment. RCP, London, England
13. WHO Technical Report Series 843 (1994) Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. World Health Organization, Geneva
14. Royal College of Physicians (2000) Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. RCP, London, England
15. Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746
16. Liberman UA, Weiss SR, Bröll J (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443
17. Tonino RP, Meunier PJ, Emkey R (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109-3115
18. Cummings SR, Black DM, Thompson DE (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture: results from the Fracture Intervention Trial. JAMA 280:2077-2082
19. Reginster J-Y, Minne HW, Sorensen OH (2000) Randomised trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83-91
20. Chesnut CH, Silverman S, Andriano K (2000) A randomized trial of nasal spray salmon calcitonin in post-menopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109:267-276
21. McClung MR, Geusens P, Miller PD (2001) Effect of risedronate treatment on hip fracture risk in elderly women. N Engl J Med 344:333-340
22. Reid IR, Brown JP, Burckhardt P (2002) Intravenous zolendronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653-661
23. Gluer C-C, Faulkner KG, Estilo MJ, Engelke K, Rosin J, Genant HK (1993) Quality assurance for bone densitometry research studies: concept and impact. Osteoporos Int 3:227-235
24. Faulkner KG, McClung MR (1995) Quality control of DXA instruments in multicenter trials. Osteoporos Int 5:218-227
25. Genant HK, Grampp S, Glüer C-C (1994) Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503-1514
26. Faulkner KG, Gluer C-C, Estilo MJ, Genant HK (1993) Cross-calibration of DXA equipment: upgrading from a Hologic QDR-1000/W to a QDR-2000. Calcif Tissue Int 52:79-84
27. Blake GM, Parker JC, Buxton FMA, Fogelman I (1993) Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans. Br J Radiol 66:902-906
28. Mazess RB, Collick B, Trempe J, Barden HS, Hanson JA (1989) Performance evaluation of a dual-energy X-ray bone densitometer. Calcif Tissue Int 44:228-232
29. Mazess RB, Hanson JA, Payne R, Nord R, Wilson M (2000) Axial and total-body bone densitometry using a narrow-angle fan-beam. Osteoporos Int 11:158-166
30. Kalender WA, Felsenberg D, Genant HK, Fischer M, Dequeker J, Reeve J (1995) The European Spine Phantom - a tool for standardization and quality control in spinal bone mineral measurements by DXA and OCT. Eur J Radiol 20:83-92
31. Mazess RB, Tempe JA, Bisek JP, Hanson JA (1991) Calibration of dual-energy X-ray absorptiometry (DEXA) for bone density. J Bone Miner Res 6:799-806
32. Hanson J (1997) Standardization of femur BMD [letter]. J Bone Miner Res 12:1316-1317
33. Altman DG (1991) Practical statistics for medical research. Chapman Hall, London
34. Blake GM (1996) Replacing DXA scanners: cross-calibration with phantoms may be misleading. Calcif Tissue Int 59:1-5
35. Blake GM, Fogelman I (1995) Replacing dual X-ray absorptiometry scanners: cross-calibration of a new multi-detector array. J Bone Miner Res 10(Suppl 1):S267
36. Steel SA, Thorpe J (2002) The GE-Lunar Prodigy: in vivo precision and cross-calibration. Calcif Tissue Int 71:277-278
37. Bolotin HH, Sievanen H, Grashuis JL, Kuiper JW, Jarvinen TLN (2001) Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation. J Bone Miner Res 16:417-426
38. Wilson CR, Carrera GF, Bergersen J (2002) The effect of patient weight on BMD measurement precision. Calcif Tissuer Int 71:281-282